RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - L'autofagia nell'omeostasi del sistema immunitario: ruolo nella patogenesi e nella progressione delle malattie autoimmuni
• 2 - Il fattore di trascrizione NF-kB nella regolazione del differenziamento ed apoptosi del sistema immune.
• 3 - Fisiopatologia della proteina prionica: nuovi approcci di studio in vitro ed in vivo
• 4 - REGOLAZIONE DELLE VIE DI SEGNALAZIONE MEDIATE DA RECETTORI DI ADESIONE IN CELLULE EMATICHE E VASCOLARI
• 5 - Studio dell’integrazione tra segnali extracellulari e controllo della proliferazione e differenziamento attraverso le modificazioni postraduzionali di fattori trascrizionali chiave.
• 6 - Modulazione dei meccanismi di apoptosi in corso di risposta immunitaria/infiammatoria: studio delle interazioni tra citochine della famiglia del TNF per la caratterizzazione di meccanismi molecolari e cellulari funzionali alla identificazione di nuovi target per la terapia di malattie croniche degenerative.
• 7 - EICOSANOIDI E MONOSSIDO DI AZOTO NEL DANNO ISCHEMICO CEREBRALE E NELLA RISOLUZIONE DELLA RISPOSTA INFIAMMATORIA AD ESSO ASSOCIATA
• 8 - Aspetti spaziotemporali nella fisiologia e patologia cellulare dei segnali mediati dai secondi messaggeri
• 9 - Ruolo di TRAIL nella fisiopatologia emopoietica e vascolare
• 10 - COMPLICANZE OSTETRICHE DA ANTICORPI ANTI-FOSFOLIPIDI: meccanismi patogenetici molecolari quali nuovi target terapeutici e marcatori prognostici.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • MALATTIE DEL SANGUE
  • REUMATOLOGIA
  • NEUROLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
• HUMAN NECESSITIES
  • AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

Classificazione geografica

• Regione: Veneto

Bibliografia

1. Butcher EC. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-6.
2. Springer TA. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 57: 827.
3. Liu, Y., S. K. Shaw, S. Ma, L. Yang, F. W. Luscinskas, and C. A. Parkos. 2004. Regulation of leukocyte transmigration: cell surface interactions and signaling events. J. Immunol. 172: 7-13.
4. Constantin, G., M. Majeed, C. Giagulli, L. Piccio, J. Y. Kim, E. C. Butcher, and C. Laudanna. 2000. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity. 13: 759-769.
5. Laudanna, C., J. Y. Kim, G. Constantin, and E. Butcher. 2002. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186: 37-46.
6. Giagulli, C., E. Scarpini, L. Ottoboni, S. Narumiya, E. C. Butcher, G. Constantin, and C. Laudanna. 2004. RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity. 20: 25-35.
7. Shamri, R., V. Grabovsky, J. M. Gauguet, et al. 2005. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 6: 497-506.
8. Xiao, T., J. Takagi, B. S. Coller, J. H. Wang, and T. A. Springer. 2004. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 432: 59-67.
9. Gakidis, M. A., X. Cullere, T. Olson, et al. 2004. Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. J. Cell Biol. 166: 273-282.
10. Feral, C. C, Rose, D. M, Han, J., Fox, N., Silverman, G. J., Kaushansky, K., Ginsberg M. H. 2006. Blocking the alpha4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site. J. Clin. Invest. 116: 715-723.
11. Totani, L., Piccoli, A., Manarini, S., Federico, L., Pecce, R., Martelli, N., Cerletti, C., Piccardoni, P., Lowell, C. A., Smyth, S. S., Berton, G., and Evangelista V. 2006. Src-family kinases mediate an outside-in signal necessary for beta2-integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leukocytes tethered on E-selectin. Biochem J. 2006 May 15;396(1):89-98.
12. Giagulli C, L. Ottoboni, E. Caveggion, B. Rossi, C. A. Lowell, G. Constantin, C. Laudanna, and G. Berton. 2006. The Src family kinases Hck and Fgr are dispensable for inside-out, chemoattractant-induced signaling regulating b2 integrin affinity and valency in neutrophils, but are required for b2 integrin-mediated outside-in signaling involved in sustained adhesion. J Immunol., in press.
13. Kinashi, T. 2005. Intracellular signalling controlling integrin activation in lymphocytes. Nat. Rev. Immunol. 5: 546-559.
14. Kim M, Carman CV, Springer TA. 2003. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science. 301:1720-5.
15. Berton, G., A. Mocsai, and C. A. Lowell. 2005. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol. 26: 208-214.
16. Lowell, C. A., and G. Berton. 1998. Resistance to endotoxic shock and reduced neutrophil migration in mice deficient for the Src-family kinases Hck and Fgr. Proc Natl Acad Sci U S A. 95: 7580-7584.
17. Vicentini, L., P. Mazzi, E. Caveggion, S. Continolo, L. Fumagalli, J. A. Lapinet-Vera, C. A. Lowell, and G. Berton. 2002. Fgr deficiency results in defective eosinophil recruitment to the lung during allergic airway inflammation. J Immunol. 168: 6446-6454.
18. Thomas, R. M., C. Schmedt, M. Novelli,et al.2004. C-terminal SRC kinase controls acute inflammation and granulocyte adhesion. Immunity. 20: 181-191.
19. Ernst, M., M. Inglese, G. M. Scholz,et al. 2002. Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J Exp Med. 196: 589-604
20. Caveggion, E., S. Continolo, F. J. Pixley, E. R. Stanley, D. D. Bowtell, C. A. Lowell, and G. Berton. 2003. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement. J Cell Physiol. 195: 276-289.
21. Suen, P. W., D. Ilic, E. Caveggion, G. Berton, C. H. Damsky, and C. A. Lowell. 1999. Impaired integrin-mediated signal transduction, altered cytoskeletal structure and reduced motility in Hck/Fgr deficient macrophages. J Cell Sci. 112 ( Pt 22): 4067-4078.
22. Meng, F., and C. A. Lowell. 1998. A b1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. Embo J. 17: 4391-4403.
23. Okigaki, M., C. Davis, M. Falasca, et al. 2003. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc Natl Acad Sci U S A. 100: 10740-10745.
24. Chiaradonna, F., L. Fontana, C. Iavarone, M. V. Carriero, G. Scholz, M. V. Barone, and M. P. Stoppelli. 1999. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence. Embo J. 18: 3013-3023.
25. Continolo, S., A. Baruzzi, M. Majeed, E. Caveggion, L. Fumagalli, C. A. Lowell, and G. Berton. 2005. The proto-oncogene Fgr regulates cell migration and this requires its plasma membrane localization. Exp Cell Res. 302: 253-269.
26. Carreno, S., E. Caron, C. Cougoule, L. J. Emorine, and I. Maridonneau-Parini. 2002. p59Hck isoform induces F-actin reorganization to form protrusions of the plasma membrane in a Cdc42- and Rac-dependent manner. J Biol Chem. 277: 21007-21016.
27. Koo, G. C., H. Rosen, A. Sirotina, X. D. Ma, and L. D. Shultz. 1993. Anti-CD11b antibody prevents immunopathologic changes in viable moth-eaten bone marrow chimeric mice. J Immunol. 151: 6733-6741.
28. Sloan DJ, Wood MJ, Charlton HM. 1992 Leucocyte recruitment and inflammation in the CNS. Trends Neurosci. 15:276-8.
29. Hickey WF, Hsu BL, Kimura H. 1991. T-lymphocyte entry into the central nervous system. J Neurosci Res. 28:254-60.
30. Merrill JE, Benveniste EN. 1996. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:331-8.
31. Holmes,G.L. 2002. Seizure-induced neuronal injury: animal data. Neurology 59: S3-S6.
32. Holmes,G.L., Khazipov,R. & Ben Ari,Y. 2002. Seizure-induced damage in the developing human: relevance of experimental models. Prog. Brain Res. 135: 321-334.
33. Duncan,J.S. 2002. Seizure-induced neuronal injury: human data. Neurology 59: S15-S20.
34. Duncan,J.S. MRI studies. 2002. Do seizures damage the brain? Prog. Brain Res. 135: 253-261.
35. Minami M, Kuraishi Y, Satoh M. 1991. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun. 176: 593-8.
36. Eriksson C, Winblad B, Schultzberg M. Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain. 1998. Brain Res Mol Brain Res. 58: 195-208.
37. Vezzani A, Moneta D, Richichi C, Perego C, De Simoni MG. 2004. Functional role of proinflammatory and anti-inflammatory cytokines in seizures. Adv Exp Med Biol. 548: 123-33.
38. Piccio L., B. Rossi, E. Scarpini, C. Giagulli, C. Laudanna, E. Butcher, A. Issekutz, D. Vestweber and G. Constantin. 2002. Molecular mechanisms involved in lymphocyte recruitment in brain microcirculation: critical roles for PSGL-1 and trimeric Galphai linked receptors. J. Immunol., 168:1940-1949.
39. Battistini L., Piccio L., Rossi B., Bach S., Galgani S., GasperiniC., Ottoboni L., Ciabini D., Caramia D., Bernardi G., Laudanna C., Scarpini E., Borsellino G. and Constantin G. 2003. CD8+ lymphocytes from acute multiple sclerosis patients display selective increase of adesiveness in brain venules: a critical role for P-selectin-glycoprotein ligand-1 (PSGL-1). Blood 101: 4775-82.

Parole Chiave

RECLUTAMENTO LEUCOCITARIO, INTEGRINE, ATTIVAZIONE INTEGRINICA, CHEMOCHINE, TRASDUZIONE DEL SEGNALE, CHINASI DELLA FAMIGLIA DEL SRC, ENCEFALOMIELITE SPERIMENTALE AUTOIMMUNE, EPILESSIA, SCLEROSI MULTIPLA